Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Health Mixed Fund C, which has seen a decline in its net value and varying returns over different time frames [1] - As of May 12, 2025, the latest net value of the fund is 1.4849 yuan, reflecting a decrease of 1.90% [1] - The fund's performance over the past month shows a return of 0.75%, ranking 1780 out of 1948 in its category; over the past three months, it has a return of -0.05%, ranking 956 out of 1931; and since the beginning of the year, it has a return of -1.56%, ranking 1595 out of 1919 [1] Group 2 - The top ten stock holdings of the fund account for a total of 55.30%, with significant positions in companies such as Heng Rui Pharmaceutical (10.60%), WuXi AppTec (9.95%), and Kanglong Chemical (6.24%) [1] - The fund was established on September 29, 2016, and as of March 31, 2025, it has a total scale of 15.566 billion yuan, managed by fund manager Ge Lan [1]
5月12日中欧医疗健康混合C净值下跌1.90%，近6个月累计下跌11.62%
Sou Hu Cai Jing·2025-05-12 12:11